510(k) device
Kappa Light Chains
SENTINEL CH. SpA · Kappa, Antigen, Antiserum, Control (DFH, Class II) · First FDA decision Sep 3, 2009, newest Sep 3, 2009Cancer detection and genomic testing
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Kappa Light Chains"
MAUDE reports
1
Brand "Kappa Light Chains", since 2015
PubMed studies
908
Mentioning "Kappa Light Chains"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Kappa Light Chains
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- KAPPA LIGHT CHAINS510(k)
K083602 · Decided Sep 3, 2009 · 272 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Kappa Light Chains", any status and sponsor, newest update first.
Chulalongkorn UniversityAcademic, hospital or other
NCT06567483 · 16 participants · Start May 1, 2023 · Primary completion Mar 1, 2024
Device: ELISIO21HX · For: Uremic; Toxemia
Sites: Pathum Wan, Thailand
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Kappa Light Chains", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code DFH
63 reports: 53 malfunction, 10 injury, 0 death
Newest reports for this brand
MW5106795 · Received Jan 18, 2022 · Event dated Dec 6, 2021
Device type: Lambda, Antigen, Antiserum, Control (DEH)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Kappa Light Chains"[tiab]. The summary above synthesizes these.
- [An unusual toothache!].
Cherif E, Ben Hassine L, Azzabi S, et al. · Rev Stomatol Chir Maxillofac Chir Orale · 2013Case Reports, English Abstract
- Bi-specific antibody engagers for cancer immunotherapy.
Ploegh H, Liu X, Le Gall C, et al. · Res Sq · 2024Preprint
- Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.
Tortosa-Carreres J, Quiroga-Varela A, Castillo-Villalba J, et al. · Mult Scler Relat Disord · 2023
- Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
Bayart JL, Muls N, van Pesch V · Acta Neurol Scand · 2018
- Light Chain Myeloma Precipitating Cryoglobulinemic Vasculitis.
Saeed B, Omar SA, Jones R, et al. · J Community Hosp Intern Med Perspect · 2023Case Reports
- Primary eyelid plasmacytoma.
Olivieri L, Di Ianni M, Giansanti M, et al. · Med Oncol · 2000Case Reports
- Waldenström macroglobulinemia-induced bullous dermatosis.
West NY, Fitzpatrick JE, David-Bajar KM, et al. · Arch Dermatol · 1998Case Reports, Review
- Pronase treatment improves flow cytometry crossmatching results.
Apithy MJ, Desoutter J, Gicquel A, et al. · HLA · 2017Clinical Trial, Research Support, Non-U.S. Gov't
- Antibody Light Chains: Key to Increased Monoclonal Antibody Yields in Expi293 Cells?
Gong S, Gautam S, Coneglio JD, et al. · Antibodies (Basel) · 2022
- Myelomatous Pleural Effusion: A Rare Occurrence in Multiple Myeloma.
Amjad MA, Hamid Z, Ramakrishna S, et al. · Cureus · 2022Case Reports
- The complexity of expressed kappa light chains in egg-laying mammals.
Nowak MA, Parra ZE, Hellman L, et al. · Immunogenetics · 2004Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Light-Chain Myeloma Presented as Osseus Tumors: A Case Report.
Huang S, Wasifuddin M, Bellamkonda A, et al. · J Investig Med High Impact Case Rep · 2024Case Reports
Other devices of this type
Also filed under product code DFH.
- N Latex FLC kappa, N Latex FLC lambdaSiemens Healthcare Diagnostics Products GmbH · 510(k) 2022
- Diazyme Human Kappa (k) Free Light Chain AssayDiazyme Laboratories, Inc. · 510(k) 2025
- Freelite Human Kappa and Lambda Free Diagnostic Test Kits for Use on the Roche Cobas Integra 400/400 Plus Analyzer KitThe Binding Site, Ltd. · 510(k) 2007
- Optilite® Freelite Mx Kappa Free KitThe Binding Site Group , Ltd. · 510(k) 2025
- FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2Sebia · 510(k) 2024
- Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitThe Binding Site, Ltd. · 510(k) 2024
- Optilite FreeLite Kappa Free Kit, Optilite Freelite Lambda Free KitThe Binding Site Group , Ltd. · 510(k) 2015
- Human Kappa and Lambda Free Kitfor Use on the Spa Plus AnalyserThe Binding Site Group , Ltd. · 510(k) 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.